Top 20 of Epstein-Barr Virus Infections

Article title # Publications/# Citations

The global health burden of infection-associated cancers in the year 2002.

2006: DMParkin;

359

Epstein-Barr virus: 40 years on.

2004: ABRickinson; LSYoung;

341

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

2002: VAppay; MCallan; VCerundolo; PRDunbar; PEasterbrook; GMGillespie; NGruener; DVHavlir; ... AKing; PKlenerman; FLechner; SLittle; AJMcMichael; GSOgg; LPapagno; GPape; DDRichman; SLRowland-Jones; MSalio; CASpina; AWaters;

316

Development of a human adaptive immune system in cord blood cell-transplanted mice.

2004: LBronz; LChicha; ALanzavecchia; MGManz; LMazzucchelli; JCPiffaretti; ETraggiai;

212

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

2001: RBiassoni; CBottino; CCantoni; MCMingari; AMoretta; LMoretta; DPende; MVitale;

207

Epstein-Barr virus: exploiting the immune system.

2001: DAThorley-Lawson;

194

Persistence of the Epstein-Barr virus and the origins of associated lymphomas.

2004: AGross; DAThorley-Lawson;

170

Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed.

2006: JPBilello; XCai; BRCullen; RCDesrosiers; REdwards; SLu; NRaab-Traub; ASchäfer;

151

Epstein-Barr virus infection.

2000: JICohen;

139

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.

2009: PJAmrolia; CMBollard; MKBrenner; GAHale; HEHeslop; JLHurwitz; HLiu; MAPule; ... RJRochester; CMRooney; ARousseau; KSSlobod; CASmith; MFWu;

110

Epstein-Barr virus in the pathogenesis of NPC.

2002: NRaab-Traub;

107

Epstein-Barr virus and virus human protein interaction maps.

2007: MACalderwood; MRChase; AEEwence; DEHill; THirozane-Kishikawa; AMHolthaus; EJohannsen; EKieff; ... NLi; AVazquez; KVenkatesan; MVidal; LXing;

106

A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers.

1999: NEAnnels; MFCallan; NGudgeon; PHansasuta; AJMcMichael; CAO'Callaghan; ABRickinson; SRowland-Jones; LCTan;

101

Environmental risk factors for multiple sclerosis. Part I: the role of infection.

2007: AAscherio; KLMunger;

101

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.

2007: CMBollard; MKBrenner; GCarrum; CCChang; APGee; SGottschalk; MVGresik; HEHeslop; ... MHHuls; MKhalil; AMLeen; CMRooney; KCStraathof; HWeiss; MFWu;

100

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell.

2000: GJBabcock; DHochberg; ADThorley-Lawson;

99

Spectrum of Epstein-Barr virus-associated diseases.

2006: JLKutok; FWang;

82

Improving T cell therapy for cancer.

2007: AEFoster; AMLeen; CMRooney;

78

Infection in solid-organ transplant recipients.

2007: JAFishman;

75

Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.

2003: MCatalina; DHochberg; KLuzuriaga; JMMiddeldorp; JLSullivan; DAThorley-Lawson;

74